| Adeel Khan, DO | |
|
13393 Determine Dr, Frisco, TX 75035-1560 | |
| (682) 288-2781 | |
| Not Available |
| Full Name | Adeel Khan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 8 Years |
| Location | 13393 Determine Dr, Frisco, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134580350 | NPI | - | NPPES |
| BP10055296 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | BP10055296 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Medical Center Grapevine | Grapevine, TX | Hospital |
| Baptist St Anthony's Hospital | Amarillo, TX | Hospital |
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the first quarter of fiscal 2011.
Scientists have developed a new test to identify patients who are at risk of suffering a relapse from testicular cancer. Assessing just three features of a common kind of testicular cancer - called non-seminomatous germ cell tumour - can identify those at most at risk of relapse even where there is no evidence of tumour spread.
Among patients with coronary artery disease referred for cardiovascular magnetic resonance and found to have regional myocardial wall thinning (of the heart muscle), limited scar burden was associated with improved contraction of the heart and reversal of wall thinning after revascularization, suggesting that myocardial thinning is potentially reversible, according to a study appearing in the March 6 issue of JAMA.
Researchers have pinpointed a part of the human brain responsible for "on-the-fly" decision-making. According to the findings published in JNeurosci, the anterior cingulate cortex integrates disparate information about the desirability and amount of an option to inform choice.
AspenBio Pharma, Inc., an in vitro diagnostic company, today announced the closing of an underwritten public offering of 1,946,000 shares of common stock at an offering price of $2.10 per share.
› Verified 5 days ago
| Entity Name | Questcare Hospitalists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265441620 PECOS PAC ID: 5799785119 Enrollment ID: O20070109000581 |
News Archive
DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the first quarter of fiscal 2011.
Scientists have developed a new test to identify patients who are at risk of suffering a relapse from testicular cancer. Assessing just three features of a common kind of testicular cancer - called non-seminomatous germ cell tumour - can identify those at most at risk of relapse even where there is no evidence of tumour spread.
Among patients with coronary artery disease referred for cardiovascular magnetic resonance and found to have regional myocardial wall thinning (of the heart muscle), limited scar burden was associated with improved contraction of the heart and reversal of wall thinning after revascularization, suggesting that myocardial thinning is potentially reversible, according to a study appearing in the March 6 issue of JAMA.
Researchers have pinpointed a part of the human brain responsible for "on-the-fly" decision-making. According to the findings published in JNeurosci, the anterior cingulate cortex integrates disparate information about the desirability and amount of an option to inform choice.
AspenBio Pharma, Inc., an in vitro diagnostic company, today announced the closing of an underwritten public offering of 1,946,000 shares of common stock at an offering price of $2.10 per share.
› Verified 5 days ago
| Entity Name | Bella Healthcare Lp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831816255 PECOS PAC ID: 8921462151 Enrollment ID: O20230906003840 |
News Archive
DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the first quarter of fiscal 2011.
Scientists have developed a new test to identify patients who are at risk of suffering a relapse from testicular cancer. Assessing just three features of a common kind of testicular cancer - called non-seminomatous germ cell tumour - can identify those at most at risk of relapse even where there is no evidence of tumour spread.
Among patients with coronary artery disease referred for cardiovascular magnetic resonance and found to have regional myocardial wall thinning (of the heart muscle), limited scar burden was associated with improved contraction of the heart and reversal of wall thinning after revascularization, suggesting that myocardial thinning is potentially reversible, according to a study appearing in the March 6 issue of JAMA.
Researchers have pinpointed a part of the human brain responsible for "on-the-fly" decision-making. According to the findings published in JNeurosci, the anterior cingulate cortex integrates disparate information about the desirability and amount of an option to inform choice.
AspenBio Pharma, Inc., an in vitro diagnostic company, today announced the closing of an underwritten public offering of 1,946,000 shares of common stock at an offering price of $2.10 per share.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adeel Khan, DO 13393 Determine Dr, Frisco, TX 75035-1560 Ph: (817) 706-0783 | Adeel Khan, DO 13393 Determine Dr, Frisco, TX 75035-1560 Ph: (682) 288-2781 |
News Archive
DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the first quarter of fiscal 2011.
Scientists have developed a new test to identify patients who are at risk of suffering a relapse from testicular cancer. Assessing just three features of a common kind of testicular cancer - called non-seminomatous germ cell tumour - can identify those at most at risk of relapse even where there is no evidence of tumour spread.
Among patients with coronary artery disease referred for cardiovascular magnetic resonance and found to have regional myocardial wall thinning (of the heart muscle), limited scar burden was associated with improved contraction of the heart and reversal of wall thinning after revascularization, suggesting that myocardial thinning is potentially reversible, according to a study appearing in the March 6 issue of JAMA.
Researchers have pinpointed a part of the human brain responsible for "on-the-fly" decision-making. According to the findings published in JNeurosci, the anterior cingulate cortex integrates disparate information about the desirability and amount of an option to inform choice.
AspenBio Pharma, Inc., an in vitro diagnostic company, today announced the closing of an underwritten public offering of 1,946,000 shares of common stock at an offering price of $2.10 per share.
› Verified 5 days ago
Michael Drew Karon, M.D, PHD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6325 Orchard Park Dr, Frisco, TX 75034 Phone: 504-251-4115 | |
Dr. Shahbaz Ahmad, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 425 Old Newman Rd Ste 402, Frisco, TX 75036 Phone: 972-499-5551 Fax: 972-499-9150 | |
Twinkle Myint, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12950 Dallas Pkwy, Frisco, TX 75033 Phone: 972-377-8695 Fax: 972-377-8699 | |
Dr. Anamika Goenka, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12400 Dallas Pkwy, Frisco, TX 75033 Phone: 469-495-2540 Fax: 215-453-4991 | |
Kalpesh Patel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5680 Frisco Square Blvd Ste 2000, Frisco, TX 75034 Phone: 469-440-2570 Fax: 214-548-5667 | |
Jasbir Dhawan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14725 Lebanon Road, Suite 100, Frisco, TX 75035 Phone: 214-705-9000 Fax: 214-619-5675 | |
Dr. Dina Renee Diehl, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13108 Dallas Pkwy Ste 430, Frisco, TX 75033 Phone: 469-200-5301 Fax: 469-687-9051 |